Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Sell
13
PHBBF Quote, Financials, Valuation and Earnings
Last price:
$1.93
Seasonality move
:
-14.22%
Day range:
$1.93 - $1.93
52-week range:
$1.93 - $2.25
Dividend yield:
1.46%
P/E ratio:
--
P/S ratio:
1.44x
P/B ratio:
1.56x
Volume:
--
Avg. volume:
--
1-year change:
-14.22%
Market cap:
$2.5B
Revenue:
--
EPS (TTM):
--
Earnings Data
Next earnings date for PHBBF
Apr 25
2025
Most recent earnings per share
$0.04
Beat by $0.04
(Mar 31/2023)
Consensus Estimate
--
(Mar 31/2023)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
PHBBF Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2023 | Q1 | -- | $398M | $0.04 | -- | -- |
| 12/31/2022 | Q4 | -- | $402.5M | $0.05 | -- | -- |
| 09/30/2022 | Q3 | -- | $404.1M | $0.05 | -- | -- |
| 06/30/2022 | Q2 | -- | $383M | $0.04 | -- | -- |
| 03/31/2022 | Q1 | -- | $330.8M | $0.03 | -- | -- |
| 12/31/2021 | Q4 | -- | $334.7M | $0.08 | -- | -- |
| 09/30/2021 | Q3 | -- | $311.3M | $0.06 | -- | -- |
| 06/30/2021 | Q2 | -- | $278M | $0.04 | -- | -- |
| 03/31/2021 | Q1 | -- | $229.6M | $0.03 | -- | -- |
| 12/31/2020 | Q4 | -- | $233.4M | $0.05 | -- | -- |
| 09/30/2020 | Q3 | -- | $201.2M | $0.04 | -- | -- |
| 06/30/2020 | Q2 | -- | $174M | $0.04 | -- | -- |
| 03/31/2020 | Q1 | -- | $137.4M | $0.01 | -- | -- |
| 12/31/2019 | Q4 | -- | $160.5M | $0.03 | -- | -- |
| 09/30/2019 | Q3 | -- | $141.1M | $0.02 | -- | -- |
| 06/30/2019 | Q2 | -- | $128M | $0.02 | -- | -- |
| 03/31/2019 | Q1 | -- | $113.1M | $0.01 | -- | -- |
| 12/31/2018 | Q4 | -- | $126.2M | $0.02 | -- | -- |
| 09/30/2018 | Q3 | -- | $112.4M | $0.02 | -- | -- |
| 06/30/2018 | Q2 | -- | $108.1M | $0.01 | -- | -- |
| 03/31/2018 | Q1 | -- | $91.5M | $0.01 | -- | -- |
| 12/31/2017 | Q4 | -- | $102.5M | $0.01 | -- | -- |
Pharmaron Beijing Earnings Questions
-
How Much did Pharmaron Beijing Generate in Revenue Last Quarter?
Pharmaron Beijing reported $398M worth of top line sales in its most recent quarter.
-
Did Pharmaron Beijing Beat Earnings Last Quarter?
Pharmaron Beijing announced earnings per share of $0.04 which represents a beat of analyst forecast a -- per share.
-
Is Pharmaron Beijing Profitable?
Pharmaron Beijing reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Pharmaron Beijing EPS Next Year?
Pharmaron Beijing's earnings are forecast to grow from -- per share to -- per share next year representing an increase of --.
-
When is Pharmaron Beijing's Earnings Date?
Pharmaron Beijing's next earnings date is April 25, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Palantir a Good Stock to Buy?
Palantir Technologies (PLTR) stock soared to its highest level in…
Why Is Sportradar Stock Going Up?
Sportradar (NASDAQ:SRAD) should be on your radar for a stock…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
